Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Breath-Holding vs. exhaling: which pushing style is safer for delivery?

NCT ID NCT02474745

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at two ways of pushing during the final stage of labor: holding your breath while pushing (Valsalva) versus pushing while exhaling (open-glottis). Researchers wanted to see which method leads to fewer injuries and better outcomes for both mother and baby. A total of 256 women who had attended childbirth classes took part, and the results help guide safer delivery practices.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

256 people

The number who actually took part.

Started

Jul 2015

Finished

Jun 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients will be women: * who are nulliparas or multiparas (≥ 1 previous child), * who attended the complete training session on the types of pushing assessed in this trial; during prenatal childbirth preparation and parenthood classes (regardless of the type of prenatal preparation) * for whom a vaginal delivery was planned at the end of pregnancy, * admitted to the maternity ward between 37 and 42 weeks of gestation (≥ 37 weeks and ≤ 42 weeks) in spontaneous or induced labor, * with cervical dilatation ≥ 7 cm, * with a singleton pregnancy in cephalic presentation, * who provided informed consent in writing * and speaks and writes French. Exclusion Criteria: * Women who are : * minors, * adults but incapable of providing consent for the study, * with a disorder contraindicating prolonged pushing, * with a uterine scar (previous cesarean or other surgery), * with a contraindication to vaginal delivery, * with a maternal disease that could justify in the short-term termination of the pregnancy (HELLP syndrome, preeclampsia \[hypertension with albuminuria \> 0.3 g by 24 hours\], eclampsia, abruptio placentae, etc.), * with a major genital hemorrhage, * with a major fetal malformation and/or hydramnios or oligohydramnios, and/or FGR (\<5°percentile), diagnosed in utero, * with a fetal heart rate anomaly before randomization, * with an in utero fetal death, * with a multiple pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for 2ND stage of labor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chu Clermont-Ferrand

    Clermont-Ferrand, 63003, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.